|
Match
|
Document |
Document Title |
|
|
5700465 |
Bovine serum and bovine IgG as preventives and therapeutives for bovine mastitis
Immunoglobulin G-2 (IgG2), e g. bovine IgG2, and its reaction with neutrophils can be used to enhance the neutrophil's functional status in host animal defense against bacterial infections.
|
|
|
5681565 |
Methods and compositions for passive immunotherapy
The direct, concentrated local delivery of antibodies, and pooled human immunoglobulins in particular, to tissue surfaces (e.g., wounds, burns, etc.), and biomaterial implant surfaces significantly...
|
|
|
5585098 |
Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
A method for lowering somatic cell count in the milk of a lactating ruminant is disclosed. IgY antibodies are first obtained from the egg of a hen which has been actively immunized against one or...
|
|
|
5571511 |
Broadly reactive opsonic antibodies that react with common staphylococcal antigens
The invention relates to the identification, making, and isolation of immunoglobulin and antigen that is useful to prevent, diagnose, or treat Staphylococcus infections. The invention further...
|
|
|
5490988 |
Delivery of therapeutic agents to a target site
An antibody fragment able to bind to a target site is prolonged by an additional peptide. The Therapeutic agent is bound to this peptide or means are provided to bring about such binding. The...
|
|
|
5460813 |
Method for treating Kawasaki syndrome by administration of an anti-TSST-1 agent which is not gamma globulin
The invention relates to various methodologies for diagnosing Kawasaki syndrome. Various bacteria, including TSST-1 producing Staphylococcus aureus, and SPEB and SPEC producing streptococcus have...
|
|
|
5439680 |
Cell-associated glucosyltransferase, an antibody thereto, and a dental caries prophylactic composition containing said antibody as an effective component
Cell-associated glucosyltransferase of S. mutans serotypes c, e or f producing dental caries was isolated and purified and its characteristics as an enzyme were revealed. Furthermore, an antibody...
|
|
|
5240704 |
Vaccine, antibodies & antibody-containing compositions for inhibiting human dental caries induced by streptococcus mutans
PLS antigens I and II are derived from the pili-like structures on the cell wall of Human type Streptococcus mutans of the serotypes c, e, f and g and the serotype d, respectively and capable of...
|
|
|
5059419 |
Streptococcus suis antiserum and its use in treating Streptococcus suis infections
An antiserum for the prevention and treatment of Streptococcus suis infections in piglets is obtained by hyperimmunization of an equine.
|
|
|
RE33403 |
Method for treating disorders of the vascular and pulmonary systems
A method for treating vascular disorders or pulmonary disorders associated with smoking in an animal which comprises: adminstering to the animal milk collected from a bovid being maintained in a...
|
|
|
4965068 |
Polyvalent hyperimmunoglobulin preparation
The present invention involves a polyvalent hyperimmunoglobulin preparation having activity against gram negative and gram positive bacteria. Such a polyvalent hyperimmunoglobulin preparation is...
|
|
|
4911910 |
Purified equine immunologlobulins and method of use thereof
Equine immunoglobulins are recovered from the pass-through fraction of a QAE column loaded with equine serum in an acidic buffer. The recovered antibodies are electrophoretically free of...
|
|
|
4885165 |
Production of anti-viral and anti-bacterial agents in combination
This invention provides for administering to donor animals a substance that generates both anti-viral agents, such as interferon, in the blood and anti-bacterial or antitoxic antibodies. This is...
|
|
|
4830852 |
Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins and methods of preparing such polysaccharides and conjugates
Covalently-modified neutral bacterial polysaccharides; covalent conjugates of such polysaccharides linked by a bigeneric spacer, with immunogenic bacterial membrane or other proteins, which...
|
|
|
4748018 |
Method of passive immunization of mammals using avian antibody
A method of passively immunizing a mammal against a condition caused by an antigen comprising: administering to the mammal immunizing amounts of an antibody obtained from a domesticated fowl which...
|
|
|
4731245 |
Vaccine, antigen and antibody for treating microorganisms of the MCLS-type streptococcus sanguis
A vaccine, comprising as antigen, at least a part of the cell of strains of Streptococcus sanguis having a high pathogenic potential and capable of decomposing raffinose and mellibiose, in...
|
|
|
4705684 |
Synthetic M proteins - streptococci type 6
Synthetic immunogenic peptides when linked to a suitable carrier elicit opsonic antibodies which are type specific for type IV streptococci are disclosed.
|
|
|
4693888 |
Caries-preventive composition
A caries-preventive composition comprises an antibody obtained by immunizing a mammal with at least one antigen selected from the group consisting of Streptococcus mutans, its cell-wall fraction,...
|
|
|
4597967 |
Synthetic polypeptide fragments
Peptide fragments of streptococcal M protein named CB3, CB4, and CB5 and related synthetic peptides have been identified. When linked to a protein carrier which is polylysine the conjugates of CB3,...
|
|
|
4594244 |
Antigenic materials
An antigenic material having a molecular weight of 3800-4500, and useful in the preparation of an anticaries vaccine is produced from a known antigenic material, antigen I/II of molecular weight...
|
|
|
4529582 |
Titration of group C streptococcal antibody
Group C streptococcal antibody levels in a serum sample can be determined via passive protection test in susceptible animals. Test is based on property of protective antibody in the serum sample to...
|
|
|
4477432 |
Oral immune globulin
There is disclosed an oral pharmaceutical composition for therapeutic use comprising a therapeutically effective amount of orally administerable immune globulin in a pharmaceutically acceptable...
|
|
|
RE31672 |
Polysaccharide antigens
Culturing Streptococcus agalactiae in a nutrient broth containing at least 10 g/l of glucose while maintaining the pH at 6-8 by the addition of alkaline material produces polysaccharide antigen...
|
|
|
4377569 |
Method of treating animals to resist infectious diseases
A method of treating an adult animal to successfully resist infectious diseases includes orally administering to the animal a mixture of an animal feed and the additive produced by the following...
|
|
|
4367222 |
Immune globulin specific to Group B streptococci
Culturing Streptococcus agalactiae in a nutrient broth containing at least 10 g/l of glucose while maintaining the pH at 6-8 by the addition of alkaline material produces polysaccharide antigen...
|
|
|
4367221 |
Immunization against Group B streptococci
Culturing Strepococcus agalactiae in a nutrient broth containing at least 10 g/l of glucose while maintaining the pH at 6-8 by the addition of alkaline material produces polysaccharide antigen...
|
|
|
4324782 |
Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells
The use of a milk product containing antibodies to Streptococcus mutans for ingestion through the oral cavity and/or application to teeth to inhibit or reduce the incidence of dental caries, and...
|
|
|
4324887 |
Type II group B Streptococci polysaccharide
Culturing Streptococcus agalactiae in a nutrient broth containing at least 10 g/l of glucose while maintaining the pH at 6-8 by the addition of alkaline material produces polysaccharide antigen...
|
|
|
4318902 |
Concentrated immunoglobulin solution suited for intravenous administration
A process for the preparation of an immunoglobulin solution containing IgM in concentrated form and suited for intravenous administration, comprising treating an IgM-containing protein fraction...
|
|
|
4197290 |
Vaccine
A vaccine effective against challenge infections, such as bovine mastitis is prepared from Staphyloccus aureus or Staphylococcus epidermidis strain.
|
|
|
4027010 |
Antistaphylococcous human immunoglobulin and method of preparing same
Antistaphylococcous human immunoglobulin consisting of gamma globulin fraction isolated from the plasma of man immunized with staphylococcous toxoid, containing staphylococcous α-antitoxin in the...
|